The AstraZeneca vaccine has been renamed

News

02.12.2025 | 18:15
Euromoney Names Ameriabank Armenia’s Best Bank for Real Estate for the Second Year in a Row
02.12.2025 | 10:00
S&P Global Ratings has assigned IDBank CJSC a long-term rating of “BB-” and a short-term rating of “B” with a “stable” prospect.
26.11.2025 | 10:00
Thanks to 129 million drams of donation from Karen Vardanyan, 17 new musical instruments were provided to the Armenian National Philharmonic Orchestra.
13.11.2025 | 19:10
War of Words: Why the Kremlin and Baku Speak the Same Language
23.10.2025 | 22:00
When the border passes through the house: Baarle, one village with two states
23.10.2025 | 14:29
Dubai Chamber of Commerce organises bilateral business forum in Yerevan to strengthen trade and investment cooperation with Armenia
16.10.2025 | 15:48
200 Scholarships for the Best Students. Ameriabank Announces a Contest for the Second Year in a Row
18.09.2025 | 15:45
Women in Agriculture: Europe’s Slowly Changing Reality
17.09.2025 | 11:57
Thanks to Barerar.am, more than 50 families’ lives were transformed in just one year
11.09.2025 | 16:30
Beyond Geopolitics: The Human Face of the EU Mission
30.05.2025 | 10:55
Mikael Vardanyan provided 3 neonatal emergency vehicles and the medical equipment amounting 118 million AMD to the Muratsan hospital complex
22.05.2025 | 11:09
Musical fountains in the Yerevan 2800th Anniversary Park
18.03.2025 | 12:45
Azerbaijan has not provided with any factual evidence of a ceasefire violation by the Armenian army: The statement of the Prime Minister’s Office
11.03.2025 | 12:23
Barerar.am  platform – the unique opportunity to become a true philanthropist
26.02.2025 | 20:08
Garant Logistics completes first cargo transportation on new China-Armenia land route
More

The vaccine against COVID-19 from the Anglo-Swedish company AstraZeneca has been renamed Vaxzevria since March 25. This is stated on the website of the European Medicines Agency (EMA). According to the Swedish Health Products Agency, the change of the name will not cause any other changes, but vaccination professionals should be aware of the renaming, as product information, labeling, and packaging may be different.  Most likely, these changes were registered against the background of the information that appeared in March, that people develop dangerous complications after being vaccinated with this vaccine. A person vaccinated in Austria was diagnosed with multiple thromboses. He died 10 days after receiving the first dose of the vaccine. Another person was hospitalized due to a pulmonary embolism. Later, such information began to be received from other European countries. Some EU countries have decided to stop vaccinating with this vaccine.